T. Duarte-Salles

First name
T.
Last name
Duarte-Salles
Barclay, N. L., Burn, E. ., Delmestri, A. ., Duarte-Salles, T. ., Golozar, A. ., . Y. Man, W. ., … Newby, D. . (2024). Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Sci Rep, 14, 19069. http://doi.org/10.1038/s41598-024-69006-1
Reyes, C. ., Newby, D. ., Raventós, B. ., Verhamme, K. ., Mosseveld, M. ., Prieto-Alhambra, D. ., … Duarte-Salles, T. . (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
Català, M. ., Mercadé-Besora, N. ., Kolde, R. ., Trinh, N. T. H., Roel, E. ., Burn, E. ., … Jödicke, A. M. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225–236. http://doi.org/10.1016/s2213-2600(23)00414-9
Català, M. ., Mercadé-Besora, N. ., Kolde, R. ., Trinh, N. T. H., Roel, E. ., Burn, E. ., … Jödicke, A. M. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. http://doi.org/10.1016/s2213-2600(23)00414-9
Raventós, B. ., Català, M. ., Du, M. ., Guo, Y. ., Black, A. ., Inberg, G. ., … Burn, E. . (2023). IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5717
Voss, E. A., Shoaibi, A. ., Lai, Y. H., Blacketer, C. ., Alshammari, T. ., Makadia, R. ., … Ryan, P. B. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
Burn, E. ., Li, X. ., Delmestri, A. ., Jones, N. ., Duarte-Salles, T. ., Reyes, C. ., … Prieto-Alhambra, D. . (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun, 13, 7167. http://doi.org/10.1038/s41467-022-34668-w
Li, X. ., Burn, E. ., Duarte-Salles, T. ., Yin, C. ., Reich, C. ., Delmestri, A. ., … Prieto-Alhambra, D. . (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
Burn, E. ., Li, X. ., Kostka, K. ., Stewart, H. M., Reich, C. ., Seager, S. ., … Prieto-Alhambra, D. . (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495–510. http://doi.org/10.1002/pds.5419
Li, X. ., Raventós, B. ., Roel, E. ., Pistillo, A. ., Martinez-Hernandez, E. ., Delmestri, A. ., … Duarte-Salles, T. . (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373